Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder, affecting more than 15 million people worldwide, with almost 5 million patients located in the United States alone [1,2]. AD is the primary cause of senile dementia and is characterized by progressive memory loss; impairments in language and visual-spatial skills; episodes of psychosis, aggressiveness, and agitation; and, ultimately, death [1,3]. The severity and the chronicity of this disease lead to institutionalization of patients and thus result in a tremendous cost for families and for society.